TLIS Share Price Performance
US$1.50
-2.26 (-60.11%)
Price US$1.50
Share PriceUS$1.50
TLIS Community Narratives
There are no narratives available yet.
Recent TLIS News & Updates
No updates
Talis Biomedical Corporation Key Details
Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -27.99
- Gross Margin
- -4,923.77%
- Net Profit Margin
- -12,506.37%
- Debt/Equity Ratio
- 0%
Talis Biomedical Corporation Competitors
About TLIS
- Founded
- 2013
- Employees
- 99
- CEO
- WebsiteView website
Talis Biomedical Corporation does not have significant operations. Previously, it was involved in the development of medical devices for infectious diseases and other conditions at the point of care in the United States. The company evaluates strategic alternatives, including acquisition, merger, reverse merger, divestiture of assets, a voluntary reorganization, dissolution or liquidation, and licensing or other strategic transactions. Talis Biomedical Corporation was incorporated in 2013 and is based in Chicago, Illinois.
U.S. Market Performance
- 7 Days: 2.3%
- 3 Months: 12.9%
- 1 Year: 20.2%
- Year to Date: 8.3%
The Consumer Staples sector gained 3.2% while the market remained flat over the last week. As for the longer term, the market has risen 20% in the past 12 months. Earnings are forecast to grow by 15% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading